Biogen (BIIB) Surges Amid Rumors of Acquisition by Samsung

Biogen (BIIB) stock gains almost 10% on Dec 29 following speculations over its potential acquisition by the South-Korean conglomerate Samsung Group. However, both parties are yet to confirm.

Leave a comment

Your email address will not be published. Required fields are marked *